...
首页> 外文期刊>Medicinal chemistry >Ligustrazine derivatives. Part 8: Design, synthesis, and preliminary biological evaluation of novel ligustrazinyl amides as cardiovascular agents
【24h】

Ligustrazine derivatives. Part 8: Design, synthesis, and preliminary biological evaluation of novel ligustrazinyl amides as cardiovascular agents

机译:川gust嗪衍生物。第8部分:作为心血管药物的新型川gust嗪酰胺的设计,合成和初步生物学评估

获取原文
获取原文并翻译 | 示例
           

摘要

A series of novel Ligustrazinyl amides was designed, synthesized and evaluated for their protective effect onthe injured vascular endothelial cells. The preliminary results demonstrated that some compounds possessed more potentactivities than that of Ligustrazine in stimulating replication of the injured human umbilical vascular endothelial cells(HUVECs) that is damaged by hydrogen peroxide. Among the active compounds, compounds 8i, 8t and 8u exhibited thehighest potency with low EC50 values of 0.037, 0.070 and 0.055 mM, respectively. Structure-activity relationships werebriefly discussed.
机译:设计,合成并评价了一系列新的川gust嗪酰胺对损伤的血管内皮细胞的保护作用。初步结果表明,某些化合物在刺激被过氧化氢损伤的人脐带血管内皮细胞(HUVEC)复制方面具有比川gust嗪更强的活性。在活性化合物中,化合物8i,8t和8u表现出最高的效力,EC50值分别为0.037、0.070和0.055 mM。简要讨论了构效关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号